Importantly, positive CNPY2 expression was associated with poorer overall survival, vessel invasion, poor histological tumor differentiation, higher clinico-pathological stage and pT factor in HCV+ HCC cases, as compared with negative expression, indicating that CNPY2 is likely to play an important role in cancer progression. The gene discussed is CNPY2; the disease is hepatocellular carcinoma.